Bristol-Myers Squibb Pharma Eeig
SpainAll drugs from this manufacturer
-
It is used to treat adults with multiple myeloma, a type of bone marrow cancer, especially when other treatments have not worked or the cancer has returned.
Dosage form: solution for injection
Active substance Dosage idecabtagen vicleucel 260–500 × 10e6 CELULAS -
It is used to treat certain types of cancer, including breast cancer (metastatic), pancreatic cancer (metastatic, in combination with gemcitabine), and non-small cell lung cancer (in combination with carboplatin).
Dosage form: powder for preparation of infusion solution
Active substance Dosage paclitaxel 100 mg -
It is used to treat chronic hepatitis B virus infection in adults and in children and adolescents from 2 to less than 18 years of age. It helps to reduce the amount of virus in the body and to improve liver health.
Dosage form: tablets, film-coated
Active substance Dosage entecvir 0,5 mg -
It is used to treat chronic hepatitis B virus (HBV) infection in adults and in children and adolescents aged 2 to less than 18 years. It helps to reduce the amount of virus in the body and to improve liver health.
Dosage form: tablets, film-coated
Active substance Dosage entecvir 1 mg -
It is used to treat adults with certain types of lymphoma (a blood cancer that affects the lymphatic tissue), including diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
Dosage form: solution for injection
Active substance Dosage lisocabtagen maraleucel 1,1-70 × 10e6 CELULAS -
It is used to treat adults with a type of heart disease called symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
Dosage form: capsules, hard
Active substance Dosage mavacamten 10 mg -
What is CAMZYOS used for?": "It is used to treat adults with a type of heart disease called symptomatic obstructive hypertrophic cardiomyopathy (oHCM).", "How should I take CAMZYOS?": "The capsule should be swallowed whole with a glass of water, approximately at the same time each day. It can be taken with or without food.", "What is the usual dose of this medicine?": "The recommended initial dose is 2.5 mg or 5 mg orally once daily. Your doctor may adjust the dose (increase, decrease, or discontinue it) based on the results of follow-up echocardiograms.", "When should I not take CAMZYOS?": "Do not take it if you are allergic to mavacamten or any of its ingredients, if you are pregnant or may become pregnant without using effective contraceptive methods, or if you are taking certain medications for infections (such as itraconazole or clarithromycin), for HIV (such as ritonavir), for cancer, or certain antibiotics.", "What side effects can CAMZYOS cause?": "Very common side effects include dizziness and difficulty breathing. Fainting may also occur. It is very important to inform your doctor immediately if you notice worsening difficulty breathing, chest pain, fatigue, palpitations, or swelling of the legs, as these could indicate serious heart failure problems.", "What should I know about pregnancy and breastfeeding?": "You must not take this medicine during pregnancy or for 6 months before attempting to become pregnant, as it may harm the fetus. You should also not breastfeed while undergoing treatment.", "Are there interactions with food or drinks?": "Caution should be exercised when consuming grapefruit juice, as it may alter the amount of medication in your body.", "What should I do if I miss a dose?": "If you forget to take it, take it as soon as you remember, provided it is the same day. Do not take a double dose to make up for the missed one."}
Dosage form: capsules, hard
Active substance Dosage mavacamten 15 mg -
It is used to treat adults with a type of heart disease called symptomatic obstructive hypertrophic cardiomyopathy (oHCM), helping to reduce excessive heart contraction and blood flow obstruction.
Dosage form: capsules, hard
Active substance Dosage mavacamten 2,5 mg -
It is used to treat adults with a type of heart disease called symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
Dosage form: capsules, hard
Active substance Dosage mavacamten 5 mg -
It is used to treat multiple myeloma (a type of bone marrow cancer) in adults, specifically when the cancer has not responded to or has returned after receiving other treatments.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage elotuzumab 400 mg -
It is used in adults and adolescents aged 12 years or older (weighing at least 35 kg) to help control human immunodeficiency virus (HIV) infection, in combination with other HIV medicines.
Dosage form: tablets, film-coated
Active substance Dosage atazanavir sulfate 341,70 mg cobicistat 294,12 mg -
It is used to treat adults with a type of cancer called multiple myeloma, either in combination with other medicines (bortezomib and dexamethasone) or with dexamethasone alone, depending on the previous treatments received.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg -
It is used to treat adults with a type of cancer called multiple myeloma, either in combination with other medicines (bortezomib and dexamethasone) or together with dexamethasone.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg -
It is used to treat adult patients with myelofibrosis (a rare type of blood cancer) who present with symptoms such as bone pain, weight loss, fever or night sweats, or who have an enlarged spleen.
Dosage form: capsules, hard
Active substance Dosage fedratinib dihydrochloride monohydrate 117,3 mg -
It is used in adults to prevent the immune system from attacking the transplanted kidney and causing transplant rejection. It is used in conjunction with other immunosuppressive medications.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage belatacept 275 mg -
It is used to treat adults with acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, in order to keep the disease under control.
Dosage form: tablets, film-coated
Active substance Dosage azacitidine 200 mg -
It is used to treat adults with acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, in order to keep the disease under control.
Dosage form: tablets, film-coated
Active substance Dosage azacitidine 300 mg -
This medication is used to treat various types of cancer, including advanced melanoma, lung cancer (non-small cell), malignant pleural mesothelioma, advanced kidney cancer, classical Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, esophageal cancer, gastric adenocarcinoma, and hepatocellular carcinoma.
Dosage form: solution for infusion, concentrate
Active substance Dosage nivolumab 47 mg/dosis -
This medicine is used to treat various types of cancer, such as advanced melanoma, lung cancer (non-small cell), malignant pleural mesothelioma, advanced kidney cancer, classical Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, colorectal cancer, esophageal cancer, gastric adenocarcinoma, and hepatocellular carcinoma.
Dosage form: solution for infusion, concentrate
Active substance Dosage nivolumab 107 mg/dosis -
What is ORENCIA used for?": "It is used in adults to treat rheumatoid arthritis and psoriatic arthritis.", "How should I take ORENCIA?": "A dose of 125 mg should be injected once a week under the skin (subcutaneously), either in the abdomen or the front of the thigh.", "When should I not use this medication?": "It should not be used if you are allergic to the active ingredient or any of its components, or if you have a serious or uncontrolled infection.", "What side effects can ORENCIA cause?": "The most frequent side effects are upper respiratory tract infections (nose, throat), headache, and nausea. Lung or urinary tract infections, fatigue, diarrhea, skin rashes, and dizziness may also occur.", "What should I do if I have an allergic reaction?": "Inform your doctor immediately if you experience swelling of the face, hands, or feet, difficulty breathing or swallowing, severe rash, or hives.", "Can I take other medications while using this treatment?": "You may use it with steroids or analgesics (such as ibuprofen or diclofenac), but you must not use it with other biological medications for rheumatoid arthritis, such as adalimumab, etanercept, or infliximab.", "What precautions should I take regarding vaccines?": "You must inform your doctor if you have been recently vaccinated or if you are planning to be, as some vaccines should not be administered during treatment.", "What happens if I miss a dose?": "If you forget a dose within a three-day period, administer it as soon as you remember and follow your usual schedule. If more than three days have passed, consult your doctor to find out when you should receive your next dose."
Dosage form: solution for injection in pre-filled pen
Active substance Dosage abatacept 125,875 mg -
It is used to treat rheumatoid arthritis and psoriatic arthritis in adults, as well as polyarticular juvenile idiopathic arthritis in children and adolescents aged 2 years and older.
Dosage form: solution for injection in a pre-filled syringe
Active substance Dosage abatacept 125,875 mg -
It is used to treat rheumatoid arthritis in adults, psoriatic arthritis in adults, and polyarticular juvenile idiopathic arthritis in children and adolescents aged 6 to 17 years.
Dosage form: solution for infusion, concentrate
Active substance Dosage abatacept 250 mg -
It is used in adults to treat anemia caused by myelodysplastic syndromes (in people who have already received other treatments or cannot receive them) and to treat anemia in adults with beta-thalassemia.
Dosage form: powder for solution for injection
Active substance Dosage luspatercept 25 mg -
It is used in adults to treat anemia caused by myelodysplastic syndromes (in people who have already received other treatments or cannot receive them) and to treat anemia in adults with β-thalassemia.
Dosage form: powder for solution for injection
Active substance Dosage luspatercept 75 mg -
It is used in adults to treat multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg -
It is used in adults to treat multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg -
It is used in adults to treat multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg -
It is used in adults to treat multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg -
It is used in adults to treat multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg -
It is used to treat adults with moderate-to-severe plaque psoriasis, an inflammatory skin condition that causes red, scaly, thick, itchy, or painful patches.
Dosage form: tablets, film-coated
Active substance Dosage deucravacitinib 6 mg -
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) and blast crisis CML in adults who have not responded to other treatments.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 20 mg -
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age. It is also used to treat Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and blast crisis CML in adults who have not responded to other treatments.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 50 mg -
It is used to treat chronic myeloid leukemia (CML) in adults, adolescents, and children at least 1 year of age, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in adults, adolescents, and children at least 1 year of age, and lymphoid blast-phase CML in adults who have not responded to prior treatments.
Dosage form: tablets, film-coated
Active substance Dosage dasatinib monohydrate 70 mg -
It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and blood cell production.
Dosage form: powder for injectable suspension
Active substance Dosage azacitidine 25 mg -
It is used to treat advanced melanoma (a type of skin cancer) in adults and adolescents aged 12 years and older. It may also be used in combination with other medicines to treat kidney cancer, malignant pleural mesothelioma, colorectal cancer, esophageal cancer, hepatocellular carcinoma, and advanced non-small cell lung cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage ipilimumab 53,5 mg -
It is used to treat advanced melanoma (a type of skin cancer) in adults and adolescents aged 12 years and older. It may also be used in combination with other medicines to treat kidney cancer, malignant pleural mesothelioma, colorectal cancer, esophageal cancer, liver cancer, and advanced non-small cell lung cancer.
Dosage form: solution for infusion, concentrate
Active substance Dosage ipilimumab 213 mg -
It is used to treat relapsing-remitting multiple sclerosis in adults with active disease and moderate to severe ulcerative colitis in adults.
Dosage form: capsules, hard
Active substance Dosage ozanimod hydrochloride 0.25 mg ozanimod hydrochloride 0,5 mg -
It is prescribed to treat adults with relapsing-remitting multiple sclerosis with active disease and adults with moderate to severe active ulcerative colitis.
Dosage form: capsules, hard
Active substance Dosage ozanimod hydrochloride 1 mg